文献速递妇产影像儿科影像技术与安全US

MSAFP筛查在产前脐膨出检测中的作用有限

Limited Role of MSAFP Screening for Prenatal Omphalocele Detection.
PubMed 文献 · J Ultrasound Med · 2024-08-27

该回顾性队列研究纳入2007至2023年本中心产前诊断的101例脐膨出妊娠,其中27例(26.7%)接受了MSAFP筛查。MSAFP筛查与脐膨出的更早怀疑或确诊无关(P=.97和P=.87),而早孕期超声筛查与更早怀疑和确诊相关(P<.01和P=.01)。MSAFP结果与脐膨出大小及产前或产后结局无关。

要点

  • MSAFP筛查未使脐膨出的怀疑或确诊时间提前。
  • 早孕期超声筛查与更早怀疑和确诊脐膨出相关。
  • MSAFP结果与脐膨出大小及临床结局无关。

核心结论

  • MSAFP筛查与脐膨出的更早检测无关,且MSAFP结果不能预测产前诊断脐膨出妊娠的临床结局。

研究设计与样本

  • 回顾性队列研究,纳入2007至2023年本中心产前诊断的101例脐膨出妊娠,比较接受与未接受MSAFP筛查者的检测时机和结局。

关键影像表现/征象

  • 27例(26.7%)接受了MSAFP筛查,筛查中位孕龄为17周4天。
  • 接受MSAFP筛查者中11例(41%)值≥2.5中位数倍数(MoM),16例(59%)未升高。

诊断标准与关键数值

  • MSAFP筛查与脐膨出怀疑时间(P=.97)和确诊时间(P=.87)均无显著关联。
  • 早孕期超声筛查与更早怀疑脐膨出(P<.01)和更早确诊(P=.01)相关。
  • MSAFP结果与脐膨出大小无关,与产前或产后结局无关。

临床应用与阅片要点

  • 产前超声检出脐膨出时,不应依赖MSAFP筛查结果来推测诊断时机或预后。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Although serum screening for aneuploidies has become less prevalent, maternal-serum alpha-fetoprotein (MSAFP) screening for body-wall defects remains widespread. We explored whether MSAFP screening is associated with earlier omphalocele detection than ultrasound alone.

METHODS: This is a retrospective cohort study of prenatally detected omphalocele cases at our center from 2007 to 2023. We explored the association between MSAFP screening, gestational age at omphalocele detection, and clinical outcomes.

RESULTS: Among 101 pregnancies with prenatally diagnosed omphalocele, 27 (26.7%) had MSAFP screening. The median gestational age at MSAFP screening was 17 weeks 4 days. Of those who received MSAFP screening, 11 (41%) had values ≥2.5 multiples of the median (MoM) and 16 (59%) were not elevated. MSAFP results did not correlate with omphalocele size and were not associated with prenatal or postnatal outcomes. MSAFP screening did not result in earlier suspicion for or confirmation of omphalocele (P = .97 and P = .87, respectively). In contrast, first-trimester ultrasound screening was associated with earlier suspicion for and confirmation of omphalocele (P < .01 and P = .01, respectively). There were no clinical or demographic differences between those who received MSAFP screening and those who did not (including body mass index or commute distance to an urban center).

CONCLUSION: MSAFP screening is not associated with earlier omphalocele detection. Furthermore, in pregnancies with prenatally diagnosed omphalocele, the results of MSAFP screening are not predictive of clinical outcomes.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Parobek CM, Shanahan MA, Burnett BA, et al. Limited Role of MSAFP Screening for Prenatal Omphalocele Detection. J Ultrasound Med. 2024. PMID: 39189734. doi:10.1002/jum.16562

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。